In addition, the UKB allowed us to study a genetic variant in CYP3A4, a key enzyme for statin metabolism,23 which was associated with decreased expression of CYP3A4 messenger RNA.43 We demonstrated that the statin-related association on liver disease was enhanced in rs35599367 minor allele carriers. The gene discussed is CYP3A4; the disease is liver disorder.